Skip to main content
Log in

Blood cytokine levels rise even after minor surgical trauma

  • Original Articles
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

The exact changes in cytokine production and clinical implications of the increased cytokine levels following operative trauma remain unclear. In this study, systemic production of a spectrum of cytokines, including IL1α, IL1β, IL6, IL8, IL10, and IFNγ, was examined in patients undergoing minor elective operative trauma. The levels of IL1 receptor antagonist (ra) and IL6 soluble receptor (sR) were also determined. Although there were no changes in IL1α and IL1β plasma levels during the entire observation period, there was a significant rise in IL1 ra level in all patients between postoperative day 1 and postoperative day 14. A significant increase in the IL6 plasma level was seen on days 1, 3, and 7 after surgery and an increase in the IL6 sR level was observed on postoperative days 10 and 14. Interestingly, the IL8 plasma values had risen significantly on days 1 and 3 following the operation. In some patients, an elevation in IL10 plasma level was noted on days 1 and 3 postsurgery. Results demonstrated that even a minor surgical procedure such as cholecystectomy with uneventful wound healing was followed by an appearance in the blood circulation of significant levels of cytokines between day 1 and day 14 after surgery. These observations point to the necessity of searching for methods of down-regulating the systemic cytokine effects after surgical trauma for the routine postoperative management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Simone C, Pugnaloni L, Cilli A, Forastieri EMA, Bernardini B, Delogu G, Sorice F: Pharmacokinetic assessment of immunosuppressive activity of antibiotics in human plasma by modification of the mixed lymphoreaction. Crit Care Med 12:483–485, 1984

    PubMed  Google Scholar 

  2. Salo M: Effects of anaesthesia and surgery on the immune response. Acta Anaesthesiol Scand 36:201–220, 1992

    PubMed  Google Scholar 

  3. Calvano S: Hormonal mediation of immune dysfunction following thermal and traumatic injury.In Advances in Host Defence Mechanism, JM Davies, GT Shires (eds). New York, Raven Press, 1986, pp 111–142

    Google Scholar 

  4. Miller CL, Baker CC: Changes in lymphocyte activity after thermal injury. The role of suppressor cells. J Clin Invest 63:202–210, 1979

    PubMed  Google Scholar 

  5. Munster AM: Post-traumatic immunosuppression is due to activation of suppressor T cells. Lancet 1:1329–1330, 1976

    PubMed  Google Scholar 

  6. Wang BS, Heacock EH, Wu AVO, Mannick JA: Generation of suppressor cells in mice after surgical trauma. J Clin Invest 66:200–209, 1980

    PubMed  Google Scholar 

  7. Winchurch RA, Munster AM: Post-traumatic activation of suppressor cells. J Reticuloendothel Soc 27:83–88, 1980

    PubMed  Google Scholar 

  8. Constantin MB, Menzoian JO, Nimberg RB, Schmid K, Mannick JA: Association of a circulating immunosuppressive polypeptide with operative and accidental trauma. Ann Surg 185:73–79, 1977

    PubMed  Google Scholar 

  9. Movat HZ: Tumor necrosis factor and interleukin-1: Role in acute inflammation and microvascular injury. J Lab Clin Med 110:668–681, 1987

    PubMed  Google Scholar 

  10. Nishimoto N, Yoshizaki K, Tagoh H, Monden M, Kishimoto S, Hirano T, Kishimoto T. Elevation of serum interleukin 6 prior to acute phase proteins on the inflammation by surgical operation. Clin Immunol Immunopathol 50:399–401, 1989

    PubMed  Google Scholar 

  11. Green DR, Faist E: Trauma and immune response. Immunol Today 9:253–255, 1988

    PubMed  Google Scholar 

  12. Akira S, Kishimoto T: IL6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev 127:25–50, 1992

    PubMed  Google Scholar 

  13. Heinrich PC, Castell JV, Andus T: Interleukin 6 and the acute phase response. Biochem J 265:621–636, 1990

    PubMed  Google Scholar 

  14. Kelso A: Cytokines: Structure, function and synthesis. Current Opin Immunol 2:215–225, 1989

    Google Scholar 

  15. Arai K, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T. Cytokines: Coordinators of immune and inflammatory responses. Annu Rev Biochem 59:783–836, 1990

    PubMed  Google Scholar 

  16. Marx JL: Cytokines are two-edged swords in disease. Science 239:257–258, 1988

    PubMed  Google Scholar 

  17. Arend WP, Malyak M, Bigler CF, Smith MF, Janson RW: The biological role of naturally-occurring cytokine inhibitors. Br J Rheumatol 30:49–52, 1991

    PubMed  Google Scholar 

  18. Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DJ, Heimdal PL, Armes LG, Sommer A, Eisenberg SP, Thompson RC: Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343:336–340, 1990

    PubMed  Google Scholar 

  19. McIntyre KW, Stepan GJ, Kokinsky KD, Benjamin WR, Plocinksy JM, Kaffka KL, Campen RA, Chizzonite RA, Killian PL: Inhibition of interleukin 1 (IL1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL1 receptor antagonist and anti-IL1 receptor monoclonal antibody. J Exp Med 173:931–939, 1991

    PubMed  Google Scholar 

  20. Ohlsson K, Bjork P, Bergenfeldt M, Hageman R, Thompson RC: Interleukin 1-receptor antagonist reduces mortality from endotoxin shock. Nature 348:550–552, 1990

    PubMed  Google Scholar 

  21. Alexander HR, Doherty GM, Buresh CM, Venzon DJ, Norton JA: A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice. J Exp Med 173:1029–1032, 1991

    PubMed  Google Scholar 

  22. Everaerdt B, Brouckaert P, Fiers W: Recombinant IL-1 receptor antagonist protects against TNF-induced lethality in mice. J Immunol 152:5041–5049, 1994

    PubMed  Google Scholar 

  23. Arend WP: Interleukin-1 receptor antagonist: A new member of the interleukin 1 family. J Clin Invest 88:1546–1451, 1991

    PubMed  Google Scholar 

  24. Dinarello CA, Thompson RC: Blocking IL-1: Interleukin-1 receptor antagonist in vivo and in vitro. Immunol Today 12:404–410, 1991

    PubMed  Google Scholar 

  25. Zamir O, O'Brien W, Thompson R, Bloedow DC, Fischer JE, Hasselgren PO: Int Reduced muscle protein breakdown in septic rats following treatment with interleukin-1 receptor antagonist. J Biochem 26:943–950, 1994

    Google Scholar 

  26. Moldawer LL: Interleukin 1, TNF alpha and their naturally occurring antagonists in sepsis. Blood Purif 11:128–133, 1993

    PubMed  Google Scholar 

  27. Tilg H, Trehu E, Atkins MB, Dinarello ChA, Mier JW: Interleukin-6 (IL-6) as an anti-inflammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83:113–118, 1994

    PubMed  Google Scholar 

  28. Rogy MA, Coyle SM, Olendburg HS, Rock CS, Barie PS, Van-Zee KJ, Smith CG, Moldawer LL, Lowry SF: Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients. J Am Cell Surg 178:132–138, 1994

    Google Scholar 

  29. van Deuren M, van der Ven Jongekrijg J, Demacker PN, Bartelink AK, van Dalen R, Sauerweien RW, Gallati H, Vannice JL, van der Meer JW: Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infection. J Infect Dis 169:157–161, 1994

    PubMed  Google Scholar 

  30. Akira S, Kishimoto T: IL6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev 127:25–50, 1992

    PubMed  Google Scholar 

  31. Heinrich PC, Castell JV, Andus T: Interleukin 6 and the acute phase response. Biochem J 265:621–636, 1990

    PubMed  Google Scholar 

  32. Clark SC: Interleukin 6. Multiple activities in regulation of the hematopoietic and immune systems. Ann NY Acad Sci 557:438–443, 1989

    PubMed  Google Scholar 

  33. Helle M, Brakenhoff JPJ, de Groot ER, Aarden LA: Interleukin 6 is involved in interleukin 1 induced activities. Eur J Immunol 18:957–959, 1988

    PubMed  Google Scholar 

  34. Ashcroft GS, Masterson GS: Interleukin-6 and wound healing. Br J Anaesth 73:426–432, 1994

    Google Scholar 

  35. Zhou D, Munster AM, Winchurch RA: Inhibitory effects of interleukin 6 on immunity. Possible implications in burn patients. Arch Surg 127:65–69, 1992

    PubMed  Google Scholar 

  36. May LT, Viguet H, Kenney JS, Ida N, Allison AC, Sehgal PB: High levels of “complexed” interleukin-6 in human blood. J Biol Chem 267:19698–19704, 1992

    PubMed  Google Scholar 

  37. May LT, Neta R, Moldawer LL, Kenney JS, Patel K, Seghal PB: Antibodies chaperone circulating IL-6. Paradoxical effects of anti-IL6 “neutralizing” antibodies in vivo. J Immunol 151:3225–3236, 1993

    PubMed  Google Scholar 

  38. Matsushima K, Oppenheim JJ: Interleukin 8 and MCAF: Novel inflammatory cytokines inducible by IL1 and TNF. Cytokine 1:2–13, 1989

    PubMed  Google Scholar 

  39. Baggiolini M, Walz A, Kunkel SL: Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84:1045–1049, 1989

    PubMed  Google Scholar 

  40. Van Zee KJ, DeForge LE, Fischer E, Marano MA, Kenney JS, Remick DG, Lowry SF, Oldawer LL: IL8 in septic shock, endotoxemia, and after IL1 administration. J Immunol 146:3478–3482, 1991

    PubMed  Google Scholar 

  41. Martich GD, Danner RL, Ceska M, Suffredini AF: Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: The effect of anti-inflammatory agents. J Exp Med 173:1021, 1991

    PubMed  Google Scholar 

  42. Danner RL, Suffredini AF, Dervort AL, Ceska M, Stetz PL, Zablotny JA, Patterson EA: Detection of interleukin 6 (IL-6) and interleukin 8 (IL-8) during septic shock in humans. Clin Res 38:352A, 1990

    Google Scholar 

  43. Garner WL, Rodriguez JL, Miller C, Smith DJ, Remick DG: Acute skin injury releases neutrophil chemoattractants. Surg Forum 42:617–618, 1991

    Google Scholar 

  44. de Waal Malefyt R, Abrams J, Bennett B, Figdor CC, de Vries JE: Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209–1220, 1991

    PubMed  Google Scholar 

  45. Pradier O, Gerard C, Delvaux A, Lybin M, Abramowicz D, Capel P, Velu T, Goldman M: Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide. Eur J Immunol 23:2700–2703, 1993

    PubMed  Google Scholar 

  46. Bogdan C, Vodovotz Y, Nathan C: Macrophage deactivation by interleukin-10. J Exp Med 174:1549–1555, 1991

    PubMed  Google Scholar 

  47. Marchant A, Deviere J, Byl B, De Grotte D, Vincent J-L., Goldman M: Interleukin-10 production during septicemia. Lancet 1:707–708, 1994

    Google Scholar 

  48. Ayala A, Deol ZK, Lehman DL, Herdon CD, Chaundry IH: Polymicrobial sepsis but not low dose endotoxin infusion causes decreased splenocyte IL2/IFN gamma release while increasing IL-4/IL-10 production. J Surg Res 56:579–585, 1994

    PubMed  Google Scholar 

  49. Abraham E, Chang Y-H: Haemorrhage-induced alterations in function and cytokine production of T cells and T cell subpopulations. Clin Exp Immunol 90:497–502, 1992

    PubMed  Google Scholar 

  50. Ayala A, Lehman DL, Herdon CD, Chaudry IH: Interleukin (IL)-10 induced suppression of T-cell responses following hemorrhage (HEM) is mediated by eicosanoids. Intens Care Med 20:S59, 1994

    Google Scholar 

  51. Miller-Graziano CL, De AK, Kodys K: Altered IL10 levels in trauma patients' MØ and T lymphocytes. J Clin Immunol 15:93–104, 1995

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grzelak, I., Olszewski, W.L., Zaleska, M. et al. Blood cytokine levels rise even after minor surgical trauma. J Clin Immunol 16, 159–164 (1996). https://doi.org/10.1007/BF01540914

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01540914

Key words

Navigation